Interventions to prevent suicidal behavior and ideation for patients with cancer: A systematic review - 10/10/19
, Naohiro Yonemoto a, c, Masatoshi Inagaki d
, Keisuke Inoue e
, Chiaki Kawanishi f, Mitsuhiko Yamada a 
Abstract |
Objective |
This study aimed to summarize interventions for suicide prevention in patients with cancer and highlight any methodological issues.
Methods |
We searched PubMed, PsycINFO, CINAHL, and the Cochrane database from their inception until July 2018. Additionally, we manually searched the references of included studies and recent systematic reviews of psychotherapy, antidepressants, and collaborative care for cancer patients with depression.
Results |
Of the 1365 retrieved articles, 11 randomized controlled trials and 11 intervention studies met the inclusion criteria. These were categorized by type of intervention: psychotherapy, pharmacotherapy, integrated collaborative care, muscle relaxation and therapeutic walking, and cancer treatment. The trials showed little evidence to confirm the effects of suicide prevention strategies. Seven trials were designed to assess the efficacy of interventions treating depression. In all studies, suicidal behavior or ideation was reported as one of the secondary outcomes. Three trials did not report information about suicidal ideation, despite assessing depressive symptoms using scales that contained suicidal ideation items. Most trials demonstrated inadequate study quality.
Conclusions |
Our review summarized interventions for suicide prevention in patients with cancer and revealed methodological issues. The findings highlighted a need to explore new treatment strategies that focus on unique suicide risk factors among patients with cancer.
Le texte complet de cet article est disponible en PDF.Keywords : Cancer, Intervention, Oncology, Self-harm, Suicide, Systematic review
Plan
Vol 60
P. 98-110 - septembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
